In the original version of this article (1) as it was published online on July 30, 2020, a reference to the study (2) reporting 23 patients from Mount Sinai included in this cohort has been inadvertently omitted from the Methods. Information on patients per hospitals in this study is now specified in the Supplementary Table S1. The HTML and PDF versions of this article were corrected on the date listed below, ahead of print. The authors regret this error.
Footnotes
Blood Cancer Discov 2020;1:290
References
- 1.Hultcrantz M, Richter J, Rosenbaum CA, Patel D, Smith ES, Korde N, et al. COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers. Blood Cancer Discov 2020;1:234–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wang B, Van Oekelen O, Mouhieddine TH, Del Valle DM, Richter J, Cho HJ, et al. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. J Hematol Oncol 2020;13:94. [DOI] [PMC free article] [PubMed] [Google Scholar]